Objects
Zhong, Michael, van der Walt, Anneke, Butler, Ernest, Prevost, Julie, Girard, Marc, Oh, Jiwon, Butzkueven, Helmut, Jokubaitis, Vilija, Monif, Mastura, Hodgkinson, Suzanne, Eichau, Sara, Kalincik, Tomas, Lechner-Scott, Jeannette, Buzzard, Katherine, Skibina, Olga, Van Pesch, Vincent. Sage Publications; 2023. Prediction of relapse activity when switching to cladribine for multiple sclerosis.
He, Anna, Spelman, Tim, Jokubaitis, Vilija, Havrdova, Eva, Horakova, Dana, Trojano, Maria, Lugaresi, Alessandra, Izquierdo, Guillermo, Grammond, Pierre, Duquette, Pierre, Girard, Marc, Pucci, Eugenio, Iuliano, Gerardo, Alroughani, Raed, Oreja-Guevara, Cekia, Fernandez-Bolaños, Ricardo, Grand'Maison, Francois, Sola, Patrizia, Spitaleri, Daniele, Granella, Franco, Lechner-Scott, Jeannette. American Medical Association; 2015. Comparison of switch to fingolimod or interferon beta/glatiramer acetate in active multiple sclerosis.
Kalincik, Tomas, Manouchehrinia, Ali, Girard, Marc, Prat, Alexandre, Duquette, Pierre, Grammond, Pierre, Sola, Patrizia, Hupperts, Raymond, Grand'Maison, Francois, Pucci, Eugenio, Boz, Cavit, Alroughani, Raed, Sobisek, Lukas, Lechner-Scott, Jeannette, , , , , , , , , , Jokubaitis, Vilija, , , , , , , , , , , Spelman, Tim, , , , , , , , Horakova, Dana, Havrdova, Eva, Trojano, Maria, Izquierdo, Guillermo, Lugaresi, Alessandra. Oxford University Press; 2017. Towards personalized therapy for multiple sclerosis: prediction of individual treatment response.
Lorscheider, Johannes, Buzzard, Katherine, Jokubaitis, Vilija, Spelman, Tim, Horakova, Dana, Trojano, Maria, Izquierdo, Guillermo, Girard, Marc, Duquette, Pierre, Prat, Alexandre, Lugaresi, Alessandra, Grand'Maison, François, Grammond, Pierre, Hupperts, Raymond, Alroughani, Raed, Sola, Patrizia, Boz, Cavit, Pucci, Eugenio, Lechner-Scott, Jeanette, Bergamaschi, Roberto, Oreja-Guevara, Celia, Iuliano, Gerardo, Van Pesch, Vincent, Granella, Franco, Ramo-Tello, Cristina, Spitaleri, Daniele, Petersen, Thor, Slee, Mark, Verheul, Freek, Ampapa, Radek, Amato, Maria Pia, McCombe, Pamela, Vucic, Steve, Sánchez Menoyo, José Luis, Cristiano, Edgardo, Barnett, Michael H., Hodgkinson, Suzanne, Olascoaga, Javier, Laura Saladino, Maria, Havrdova, Eva, Gray, Orla, Shaw, Cameron, Moore, Fraser, Butzkueven, Helmut, Kalincik, Tomas. Oxford University Press; 2016. Defining secondary progressive multiple sclerosis.
Kalincik, Tomas, Jokubaitis, Vilija, Grand'Maison, Francois, Pucci, Eugenio, Van Pesch, Vincent, Boz, Cavit, Iuliano, Gerardo, Fernandez-Bolanos, Ricardo, Flechter, Shlomo, Spitaleri, Daniele, Cristiano, Edgardo, Verheul, Ferek, Izquierdo, Guillermo, Lechner-Scott, Jeannette, Amato, Maria Pia, Cabrera-Gomez, Jose Antonio, Saladino, Maria Laura, Slee, Mark, Moore, Fraser, Gray, Orla, Paine, Mark, Barnett, Michael, Havrdova, Eva, Duquette, Pierre, Horakova, Dana, Spelman, Timothy, Trojano, Maria, Butzkueven, Helmut, , , Girard, Marc, Grammond, Pierre, Lugaresi, Alessandra, Oreja-Guevara, Celia, Bergamaschi, Roberto, Hupperts, Raymond. Sage; 2014. Comparative effectiveness of glatiramer acetate and interferon beta formulations in relapsing-remitting multiple sclerosis.
Fambiatos, Adam, Jokubaitis, Vilija, Grand'Maison, Francois, Grammond, Pierre, Sola, Patricia, Ferraro, Diana, Alroughani, Raed, Terzi, Murat, Hupperts, Raymond, Boz, Cavit, Lechner-Scott, Jeannette, Pucci, Eugenio, Horakova, Dana, Bergamaschi, Roberto, Van Pesch, V, Ozakbas, S, Granella, F, Turkoglu, R, Iuliano, G, Spitaleri, D, McCombe, P, Solaro, C, Slee, M, Kubala Havrdova, Eva Kubala, Ampapa, R, Soysal, A, Petersen, T, Sanchez-Menoyo, JL, Verheul, F, Prevost, J, Sidhom, Y, Van Wijmeersch, B, Vucic, S, Cristiano, E, Trojano, Maria, Saladino, ML, Deri, N, Barnett, M, Olascoaga, J, Moore, F, Skibina, O, Gray, O, Fragoso, Y, Yamout, B, Shaw, C, Prat, Alexandre, Singhal, B, Shuey, N, Hodgkinson, S, Altintas, A, Al-Harbi, T, Csepany, T, Taylor, B, Hughes, J, Jun, J-K, van der Walt, A, Girard, Marc, Spelman, T, Butzkueven, H, Kalincik, T, Duquette, Pierre, Lugaresi, Alessandra, Izquierdo, Guillermo. Sage; 2020. Risk of secondary progressive multiple sclerosis: a longitudinal study.
Kalincik, Thomas, Cutter, Gary, Prat, Alexandre, Lugaresi, Alessandra, Grand'Maison, Francois, Grammond, Pierre, Hupperts, Raymond, Oreja-Guevara, Celia, Boz, Cavit, Pucci, Eugenio, Bergamaschi, Roberto, Lechner-Scott, Jeannette, Spelman, Tim, Alroughani, Raed, Van Pesch, Vincent, Iuliano, Gerardo, Fernandez-Bolaños, Ricardo, Ramo, Cristina, Terzi, Murat, Slee, Mark, Spitaleri, Daniele, Verheul, Freek, Cristiano, Edgardo, Jokubaitis, Vilija, Sánchez-Menoyo, José Luis, Fiol, Marcela, Gray, Orla, Cabrera-Gomez, Jose Antonio, Barnett, Michael, Butzkueven, Helmut, Havrdova, Eva, Horakova, Dana, Trojano, Maria, Izquierdo, Guillermo, Girard, Marc, Duquette, Pierre. Oxford University Press; 2015. Defining reliable disability outcomes in multiple sclerosis.
Hughes, Jordana, Jokubaitis, Vilija, Lugaresi, Alessandra, Hupperts, Raymond, Izquierdo, Guillermo, Prat, Alexandre, Girard, Marc, Duquette, Pierre, Grand'Maison, Francois, Grammond, Pierre, Sola, Patrizia, Ferraro, Diana, Ramo-Tello, Cristina, Trojano, Maria, Slee, Mark, Shaygannejad, Vahid, Boz, Cavit, Lechner-Scott, Jeanette, Van Pesch, Vincent, Pucci, Eugenio, Solaro, Claudio, Verheul, Freek, Terzi, Murat, Granella, Franco, Spitaleri, Daniele, Alroughani, Raed, Jun, Jae-Kwan, Fambiatos, Adam, Van der Walt, Anneke, Butzkueven, Helmut, Kalincik, Tomas. American Medical Association (AMA); 2018. Association of inflammation and disability accrual in patients with progressive-onset multiple sclerosis.
Kalincik, Tomas, Vivek, Vino, Bergamaschi, Roberto, Iuliano, Gerardo, Alroughani, Raed, Van Pesch, Vincent, Amato, Maria Pia, Slee, Mark, Verheul, Freek, Fernandez-Bolanos, Ricardo, Fiol, Marcela, La Spitaleri, Daniele, Jokubaitis, Vilija, , , , , , , , , , , Lechner-Scott, Jeannette, , , , , , , , , , , Trojano, Maria, , , , , , , , , , Izquierdo, Guillermo, Lugaresi, Alessandra, Grand’Maison, Francois, Hupperts, Raymond, Oreja-Guevara, Celia. Oxford University Press; 2013. Sex as a determinant of relapse incidence and progressive course of multiple sclerosis.
Kalincik, Tomas, Horakova, Dana, Spelman, Tim, Jokubaitis, Vilija, Trojano, Maria, Lugaresi, Alessandra, Izquierdo, Guillermo, Rozsa, Csilla, Grammond, Pierre, Alroughani, Raed, Duquette, Pierre, Girard, Marc, Pucci, Eugenio, Lechner-Scott, Jeannette, Slee, Mark, Fernandez-Bolanos, Ricardo, Grand'Maison, Francois, Hupperts, Raymond, Verheul, Freek, Hodgkinson, Suzanne. John Wiley & Sons; 2015. Switch to natalizumab versus fingolimod in active relapsing-remitting multiple sclerosis.
Kalincik, Tomas, Brown, J. William L., McGuigan, Christopher, Jokubaitis, Vilija, Spelman, Tim, Horakova, Dana, Havrdova, Eva, Trojano, Maria, Izquierdo, Guillermo, Lugaresi, Alessandra, Prat, Alexandre, Girard, Marc, Robertson, Neil, Lechner-Scott, Jeannette, , , , , , , , , , Willis, Mark, , , , , , , , , , , Scolding, Neil, , , , , , , , , , , Rice, Claire M., Wilkins, Alastair, Pearson, Owen, Ziemssen, Tjalf, Hutchinson, Michael. Lancet Publishing; 2017. Treatment effectiveness of alemtuzumab compared with natalizumab, fingolimod, and interferon beta in relapsing-remitting multiple sclerosis: a cohort study.
Kalincik, Tomas, Buzzard, Katherine, Oreja-Guevara, Celia, Boz, Cavit, Hupperts, Raymond, Petersen, Thor, Giuliani, Giorgop, Iuliano, Gerardo, Lechner-Scott, Jeannette, Barnett, Michael, Bergamaschi, Roberto, Van Pesch, Vincent, Jokubaitis, Vilija, Amato, Maria Pia, van Munster, Erik, Fernandez-Bolanos, Ricardo, Verheul, Freek, Fiol, Marcela, Cristiano, Edgardo, Slee, Mark, Rio, Maria Edite, Spitaleri, Daniele, Alroughani, Raed, Trojano, Maria, Gray, Orla, Saladino, Maria Laura, Flechter, Sholmo, Herbert, Joseph, Cabrera-Gomez, Jose Antonio, Vella, Norbert, Paine, Mark, Shaw, Cameron, Moore, Fraser, Vucic, Steve, Duquette, Pierre, Savino, Aldo, Singhal, Bhim, Petkovska-Boskova, Tatjana, Parratt, John, Sirbu, Carmen-Adella, Rozsa, Csilla, Liew, Danny, Butzkueven, Helmut, , Izquierdo, Guillermo, Girard, Marc, Lugaresi, Alessandra, Grammond, Pierre, Grand'Maison, Francois. Sage Publications; 2014. Risk of relapse phenotype recurrence in multiple sclerosis.
Spelman, Tim, Kalincik, Tomas, Havrdová, Eva, Horáková, Dana, Grammond, Pierre, Duquette, Pierre, Prat, Alexandre, Iuliano, Gerardo, Terzi, Murat, Izquierdo, Guillermo, Hupperts, Raymond M.M., , Jokubaitis, Vilija, , , , , Lechner-Scott, Jeannette, , , , , , Zhang, Annie, , Pellegrini, Fabio, Wiendl, Heinz, Belachew, Shibeshih, Hyde, Robert, Verheul, Freek, Lugaresi, Alessandra. Lippincott Williams & Wilkins; 2016. Comparative efficacy of first-line natalizumab vs IFN-ß or glatiramer acetate in relapsing MS.
Maltby, Vicki, Xavier, Alexandre, Slee, Mark, van der Mei, Ingrid A., Taylor, Bruce V., Ponsonby, Anne-Louise, Jagodic, Maja, Lea, Rodney, Lechner-Scott, Jeannette, Ewing, Ewoud, Campagna, Maria-Pia, Sampangi, Sandeep, Scott, Rodney J., Butzkueven, Helmut, Jokubaitis, Vilija, Kular, Lara, Bos, Steffan. Wolters Kluwer; 2023. Evaluation of Cell-Specific Epigenetic Age Acceleration in People With Multiple Sclerosis.
Yeh, Wei Zhen, Gresle, Melissa, Sampangi, Sandeep, Campagna, Maria Pia, Stankovich, Jim, Van der Walt, Anneke, Jokubaitis, Vilija, Butzkueven, Helmut, Lea, Rodney, Taylor, Bruce, Lucas, Robyn M., Ponsonby, Anne-Louise, Mason, Deborah, Andrew, Julie, Campbell, Hamish, Morahan, Julia. Academic Press; 2024. The immune cell transcriptome is modulated by vitamin D3 supplementation in people with a first demyelinating event participating in a randomized placebo-controlled trial.